JPS5719106B2 - - Google Patents

Info

Publication number
JPS5719106B2
JPS5719106B2 JP8154572A JP8154572A JPS5719106B2 JP S5719106 B2 JPS5719106 B2 JP S5719106B2 JP 8154572 A JP8154572 A JP 8154572A JP 8154572 A JP8154572 A JP 8154572A JP S5719106 B2 JPS5719106 B2 JP S5719106B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8154572A
Other versions
JPS4829770A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4829770A publication Critical patent/JPS4829770A/ja
Publication of JPS5719106B2 publication Critical patent/JPS5719106B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8154572A 1971-08-16 1972-08-16 Expired JPS5719106B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17232171A 1971-08-16 1971-08-16
US00268380A US3821244A (en) 1971-08-16 1972-07-03 2-amino-4-phenyl-2-imidazolines

Publications (2)

Publication Number Publication Date
JPS4829770A JPS4829770A (ja) 1973-04-19
JPS5719106B2 true JPS5719106B2 (ja) 1982-04-20

Family

ID=26867960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8154572A Expired JPS5719106B2 (ja) 1971-08-16 1972-08-16

Country Status (16)

Country Link
US (1) US3821244A (ja)
JP (1) JPS5719106B2 (ja)
BE (1) BE787617A (ja)
CA (1) CA1018174A (ja)
CH (2) CH591451A5 (ja)
DE (1) DE2240256A1 (ja)
DK (1) DK139098B (ja)
FR (1) FR2150766B1 (ja)
GB (1) GB1347930A (ja)
HU (1) HU165660B (ja)
IE (1) IE36865B1 (ja)
IL (1) IL40123A (ja)
NL (1) NL7211173A (ja)
PH (2) PH11940A (ja)
SE (1) SE406763B (ja)
YU (1) YU35355B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914249A (en) * 1973-10-30 1975-10-21 Mead Johnson & Co 4-(3,4-Dichlorophenyl)-2-(methylamino)-2-imadazoline
US3953349A (en) * 1973-12-13 1976-04-27 Standard Oil Company Oil-soluble reaction products of (A) a high molecular weight olefin polymer, acetonitrile, and chlorine with (B) an amine, and lubricant compositions containing the same
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
JPS5877051U (ja) * 1981-11-16 1983-05-24 富士通株式会社 Ｉｃアダプタ
EP0200947B1 (de) * 1985-04-26 1990-09-12 F. Hoffmann-La Roche Ag 1,3-Disubstituierte Imidazoliumsalze
EP0853626A1 (en) * 1995-09-07 1998-07-22 Novartis AG Substituted phosphinic compounds and their use as pharmaceuticals
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
DE2240256A1 (de) 1973-02-22
GB1347930A (en) 1974-02-27
SE406763B (sv) 1979-02-26
YU207472A (en) 1980-06-30
HU165660B (ja) 1974-10-28
CA1018174A (en) 1977-09-27
PH11915A (en) 1978-09-08
IE36865B1 (en) 1977-03-16
DK139098B (da) 1978-12-18
IL40123A (en) 1975-05-22
FR2150766B1 (ja) 1976-05-21
PH11940A (en) 1978-09-15
NL7211173A (ja) 1973-02-20
FR2150766A1 (ja) 1973-04-13
CH579055A5 (ja) 1976-08-31
IL40123A0 (en) 1972-10-29
BE787617A (fr) 1973-02-16
US3821244A (en) 1974-06-28
YU35355B (en) 1980-12-31
DK139098C (ja) 1979-05-28
IE36865L (en) 1973-02-16
CH591451A5 (ja) 1977-09-15
JPS4829770A (ja) 1973-04-19

Similar Documents

Publication Publication Date Title
AU474595B2 (ja)
FR2150766B1 (ja)
AU2658571A (ja)
AU2691671A (ja)
AU2684071A (ja)
AU2742671A (ja)
AU2894671A (ja)
AU2755871A (ja)
AU2740271A (ja)
AU2503871A (ja)
AU2940971A (ja)
AU2669471A (ja)
AU2938071A (ja)
AU2885171A (ja)
AU2880771A (ja)
AU2875571A (ja)
AU2854371A (ja)
AU2837671A (ja)
AU2836771A (ja)
AU2907471A (ja)
AU2684171A (ja)
AU2927871A (ja)
AU2930871A (ja)
AU2706571A (ja)
AU2724971A (ja)